Control of hepatic gluconeogenesis by the promyelocytic leukemia zinc finger protein

Molecular Endocrinology

Volumn 28, Issue 12, 2014, Pages 1987-1998

  Chen, Siyu ^a   Qian, Jinchun ^a   Shi, Xiaoli ^a   Gao, Tingting ^a   Liang, Tingming ^a   Liu, Chang ^a,b  

^a NANJING NORMAL UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GLUCOCORTICOID RECEPTOR; GLUCOSE; INSULIN; LIVER PROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROMYELOCYTIC LEUKEMIA PROTEIN; PROMYELOCYTIC LEUKEMIA ZINC FINGER PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; KRUPPEL LIKE FACTOR; ZBTB16 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION; GENE SILENCING; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; GLYCEMIC CONTROL; HEPATIC GLUCONEOGENESIS; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TOLERANCE TEST; LIVER CELL; MALE; MOUSE; NONHUMAN; NONVIRAL GENE THERAPY; PLASMID; PROTEIN EXPRESSION; RNA INTERFERENCE; SKELETAL MUSCLE; TRANSIENT TRANSFECTION; VIRAL GENE DELIVERY SYSTEM; WHITE ADIPOSE TISSUE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; GENETICS; IMMUNOPRECIPITATION; LIVER; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL LINE; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; GLUCONEOGENESIS; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; IMMUNOPRECIPITATION; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIVER; MALE; MICE; MICE, INBRED C57BL;

EID: 84914158653     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2014-1164     Document Type: Article

References (44)

1. van Schaftingen E, Gerin I. The glucose-6-phosphatase system. Biochem J. 2002;362(Pt 3):513-532.
2. Pilkis SJ, Granner DK. Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Physiol. 1992; 54:885-909.
3. Nordlie RC, Foster JD, Lange AJ. Regulation of glucose production by the liver. Annu Rev Nutr. 1999;19:379-406.
4. Sutherland C, O’Brien RM, Granner DK. Phosphatidylinositol 3-kinase, but not p70/p85 ribosomal S6 protein kinase, is required for the regulation of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by insulin. Dissociation of signaling pathways for insulin and phorbol ester regulation of PEPCK gene expression. J Biol Chem. 1995;270:15501-15506.
5. Firth RG, Bell PM, Marsh HM, Hansen I, Rizza RA. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. J Clin Invest. 1986; 77:1525-1532.
6. Biddinger SB, Kahn CR. From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol. 2006;68:123-158.
7. Liu C, Lin JD. PGC-1 coactivators in the control of energy metabolism. Acta Biochim Biophys Sin. 2011;43:248-257.
8. Herzig S, Long F, Jhala US, et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature. 2001;413:179-183.
9. Yoon JC, Puigserver P, Chen G, et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature. 2001;413:131-138.
10. Puigserver P, Rhee J, Donovan J, et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1α interaction. Nature. 2003;423:550-555.
11. Koo SH, Satoh H, Herzig S, et al. PGC-1 promotes insulin resistance in liver through PPAR-α -dependent induction of TRB-3. Nat Med. 2004;10:530-534.
12. Chen Z, Brand NJ, Chen A, et al. Fusion between a novel Krüppellike zinc finger gene and the retinoic acid receptor-α locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J. 1993;12:1161-1167.
13. Ching YH, Wilson LA, Schimenti JC. An allele separating skeletal patterning and spermatogonial renewal functions of PLZF. BMC Dev Biol. 2010;10:33.
14. Reid A, Gould A, Brand N, et al. Leukemia translocation gene, PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors. Blood. 1995;86:4544-4552.
15. Doulatov S, Notta F, Rice KL, et al. PLZF is a regulator of homeostatic and cytokine-induced myeloid development. Gene Dev. 2009;23:2076-2087.
16. Xu D, Holko M, Sadler AJ, et al. Promyelocytic leukemia zinc finger protein regulates interferon-mediated innate immunity. Immunity. 2009;30:802-816.
17. Seda O, Liska F, Sedová L, Kazdová L, Krenová D, Kren V. A 14-gene region of rat chromosome 8 in SHR-derived polydactylous congenic substrain affects muscle-specific insulin resistance, dyslipidaemia and visceral adiposity. Folia Biol (Praha). 2005;51(3): 53-61.
18. Plaisier CL, Bennett BJ, He A, et al. Zbtb16 has a role in brown adipocyte bioenergetics. Nutr Diabetes. 2012;2:e46.
19. Cao J, Zhu S, Zhou W, et al. PLZF mediates the PTEN/AKT/ FOXO3a signaling in suppression of prostate tumorigenesis. Plos One. 2013;8:e77922.
20. Meijsing SH, Pufall MA, So AY, Bates DL, Chen L, Yamamoto KR. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science. 2009;324:407-410.
21. Barna M, Hawe N, Niswander L, Pandolfi PP. Plzf regulates limb and axial skeletal patterning. Nat Genet. 2000;25:166-172.
22. Buaas FW, Kirsh AL, Sharma M, et al. Plzf is required in adult male germ cells for stem cell self-renewal. Nat Genet. 2004;36:647-652.
23. Rho SB, Park YG, Park K, Lee SH, Lee JH. A novel cervical cancer suppressor 3 (CCS-3) interacts with the BTB domain of PLZF and inhibits the cell growth by inducing apoptosis. FEBS Lett. 2006; 580:4073-4080.
24. Brunner G, Reitz M, Schwipper V, et al. Increased expression of the tumor suppressor PLZF is a continuous predictor of long-term survival in malignant melanoma patients. Cancer Biother Radiopharm. 2008;23:451-459.
25. Felicetti F, Bottero L, Felli N, et al. Role of PLZF in melanoma progression. Oncogene. 2004;23:4567-4576.
26. Shiraishi K, Yamasaki K, Nanba D, et al. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zincfinger-mediated melanoma cell growth suppression. Oncogene. 2007;26:339-348.
27. Suliman BA, Xu D, Williams BR. The promyelocytic leukemia zinc finger protein: two decades of molecular oncology. Front Oncol. 2012;2:74.
28. Labbaye C, Quaranta MT, Pagliuca A, et al. PLZF induces megakaryocytic development, activates Tpo receptor expression and interacts with GATA1 protein. Oncogene. 2002;21:6669-6679.
29. Senbonmatsu T, Saito T, Landon EJ, et al. A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J. 2003;22:6471-6482.
30. Labbaye C, Spinello I, Quaranta MT, et al. A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat Cell Biol. 2008;10:788-801.
31. Felicetti F, Errico MC, Bottero L, et al. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res. 2008;68:2745-2754.
32. Zu XL, Guppy M. Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Commun. 2004;313:459-465.
33. Wang Y, Zhang L, Chen WL, et al. Rapid diagnosis and prognosis of de novo acute myeloid leukemia by serum metabonomic analysis. J Proteome Res. 2013;12:4393-4401.
34. Ma R, Zhang W, Tang K, et al. Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma. Nat Commun. 2013;4:2508.
35. Wei S, Zhang L, Zhou X, et al. Emerging roles of zinc finger proteins in regulating adipogenesis. Cell Mol Life Sci. 2013;70:4569-4584.
36. Georgiadi A, Boekschoten MV, Müller M, Kersten S. Detailed transcriptomics analysis of the effect of dietary fatty acids on gene expression in the heart. Physiol Genomics. 2012;44:352-361.
37. Pond CM, Mattacks CA, Sadler D. The effects of food restriction and exercise on site-specific differences in adipocyte volume and adipose tissue cellularity in the guinea-pig. 2. Intermuscular sites. Br J Nutr. 1984;51:425-433.
38. Djurhuus CB, Gravholt CH, Nielsen S, et al. Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans. Am J Physiol Endocrinol Metab. 2002;283:E172-E177.
39. Rose AJ, Vegiopoulos A, Herzig S. Role of glucocorticoids and the glucocorticoid receptor in metabolism: insights from genetic manipulations. J Steroid Biochem Mol Biol. 2010;122:10-20.
40. Walker BR. Glucocorticoids and cardiovascular disease. Eur J Endocrinol. 2007;157:545-559.
41. Crabtree GR, Gillis S, Smith KA, Munck A. Glucocorticoids and immune responses. Arthritis Rheum. 1979;22:1246-1256.
42. Wan Y, Nordeen SK. Overlapping but distinct gene regulation profiles by glucocorticoids and progestins in human breast cancer cells. Mol Endocrinol. 2002;16:1204-1214.
43. Fahnenstich J, Nandy A, Milde-Langosch K, Schneider-Merck T, Walther N, Gellersen B. Promyelocytic leukaemia zinc finger protein (PLZF) is a glucocorticoid- and progesterone-induced transcription factor in human endometrial stromal cells and myometrial smooth muscle cells. Mol Hum Reprod. 2003;9:611-623.
44. White MF. Metformin and insulin meet in a most atypical way. Cell Metab. 2009;9:485-487.